Thriving in Global Business Transformation: What Opportunities Boost Leadership?

In 2023, biotechnology bankruptcies surged to a record high, with over 20 companies failing due to fierce competition, slow financial recovery, and product failures. In such a turbulent environment, a strong investor finance strategy focusing on competitive intelligence is essential for growth.?

Frost & Sullivan’s Growth Opportunity Newsletter delivers critical market intelligence to help your company excel in the healthcare and life sciences industries. It offers guidance on building a competitive product portfolio that meets diverse needs, from athletes to diabetes patients.?

Has your company identified the most promising avenues for growth?

Explore the answers to key healthcare questions addressed in this edition:??

• Is 3D printing and generative AI revolutionizing sports medicine??

• How is AI integration transforming the hospital-at-home model for high-acuity and chronic conditions, and what is its impact on growth and logistics??

• What untapped growth opportunities are emerging in digital respiratory solutions for your company??

• Is personalized medicine and cutting-edge drug delivery transforming oral solid dosage forms??

Why are diabetes and obesity therapeutics a growing concern? Is your company equipped to navigate the booming healthcare industry????

Frost & Sullivan expects that by 2050, the global population will reach 9 billion, with post-pandemic lifestyles worsening obesity and increasing the risk of type 2 diabetes. This is leading to a growing need for treatments that tackle both obesity and diabetes (diabesity) simultaneously.?

Industry intelligence overview:??

• Growth Gaps: Current obesity drugs have limited safety and efficacy, fueling demand for newer options like GLP-1 receptor agonists, which offer better glycemic control and weight loss.?

• Business Models: Emerging direct-to-consumer and hybrid care models are focusing on integrating pharmacotherapy with nutrition, behavioral, and lifestyle interventions.?

• Competitive Differentiation: Life sciences companies are developing safer, more effective therapies with lower dosing frequencies, sustained weight loss, and better cardiometabolic outcomes, along with innovations in drug delivery.?

• Strategic Partnerships: Precision medicine research is growing, with collaborations like those between the Novo Nordisk Foundation Centre and the Broad Institute advancing understanding of gene regulation in obesity and diabetes.???

The healthcare industry is set for major growth with advances in data and technology. CROs like Icon plc, Novotech, Syneos Health, and IQVIA, along with companies like BMS, are utilizing AI for better site selection and patient recruitment. With lab tests influencing 70% of clinical decisions and increasing due to aging populations and rising diseases, understanding patient engagement is essential for success in the shift towards patient-centered care and digital innovation.?

Growth opportunities in the healthcare industry:??

• Integrated AI solutions in clinical trial design, site selection, and patient management are streamlining go-to-market strategies for CROs and pharmaceutical companies.?

• The life science instrumentation and research tools industries are growing, driven by laboratory automation and software solutions.?

• Labs are leveraging digitization and automation to meet evolving consumer demands for convenience, affordability, and speed, with robotic automation and advanced lab monitoring becoming key.?

• Generative AI is enhancing end-user experiences and shaping hospital workflows in the US and Europe, adapting to post-COVID-19 industry changes.?

• The rise of industry clouds in healthcare is accelerating AI adoption, with public cloud providers developing foundational models and user-friendly tools.?

• Home care and remote monitoring solutions are fuelling the patient monitoring industry, with new vendors introducing wearables and contactless options.?

?Find out what opportunities do patient monitoring industry hold for your growth:??

Top Strategic Imperatives for Growth???????

Top 10 Strategic Imperatives: Navigating the AI-Driven Revolution in Precision Health?

• Harnessing growth opportunities in generative AI for personalized medicine.?

• Adopting best practices to advance gene editing and drug discovery with AI.?

• Achieving growth by fusing AI with biotechnology for personalized treatments.?

Explore More Growth Opportunities:

Don’t miss out on our Transformational Journey section which provides thought leadership to execute key growth opportunities.

What Opportunities Are Driving Growth for Cardiovascular Devices and Respiratory Care??

Assess how real-time monitoring technology, strategic partnerships, smart devices, and remote care can be utilized to manage chronic diseases efficiently for growth.?

This is a short version of Frost & Sullivan’s Growth Opportunity Newsletter. Sign up here to get the full edition in your inbox every month.